MENU

ABUS Arbutus Biopharma Corp Forecast, Technical & Fundamental Analysis

a developer of drugs to improve the treatment of cancer

Industry Biotechnology
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ABUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ABUS is expected to report earnings to fall 14.00% to -8 cents per share on February 27

Arbutus Biopharma Corp ABUS Stock Earnings Reports
Q4'24
Est.
$-0.09
Q3'24
Missed
by $0.01
Q2'24
Missed
by $0.01
Q1'24
Est.
$-0.10
Q4'23
Est.
$-0.12
The last earnings report on November 06 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 465.68K shares outstanding, the current market capitalization sits at 655.64M.
A.I. Advisor
published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
701 Veterans Circle
Phone
+1 267 469-0914
Employees
73
Web
http://www.arbutusbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ABUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ABUS has been loosely correlated with THRD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ABUS jumps, then THRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABUS
1D Price
Change %
ABUS100%
-2.54%
THRD - ABUS
39%
Loosely correlated
+2.07%
ROIV - ABUS
38%
Loosely correlated
+0.41%
IDYA - ABUS
37%
Loosely correlated
+1.07%
ERAS - ABUS
36%
Loosely correlated
+0.38%
ALDX - ABUS
36%
Loosely correlated
+5.34%
More